Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03291743 · ClinicalTrials.gov registry record · NA
The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives
A NA study, sponsored by Carilion Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03291743 is a NA study that was terminated before completion, run by Carilion Clinic. The registered enrollment target is 38 participants.
The verdict
NCT03291743, a NA study, was terminated before completion, sponsored by Carilion Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Pursuing very early diagnosis is standard of care for several diseases including colon cancer, diabetes and liver disease where an early and aggressive diagnostic and therapeutic approach has been shown to change their natural history. Crohn's disease \[CD\] still lags since commonly at presentation CD has already run a long course, often responding poorly to therapy or requiring surgery. This innovative project proposes a minimally invasive strategy - capsule endoscopy-based screening of first degree relatives \[FDR's\] of CD patients - to develop tools to diagnose CD at or near its biologic onset.
Interventions
- DEVICE Capsule endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03291743
The ClinicalTrials.gov registry entry for NCT03291743 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Capsule endoscopy is the first listed.
NCT03291743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03291743 about?
NCT03291743 is a clinical study titled "The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives". Pursuing very early diagnosis is standard of care for several diseases including colon cancer, diabetes and liver disease where an early and aggressive diagnostic and therapeutic approach has been shown to change their natural history. Crohn's disease \[CD\] still lags since commonly at presentation...
What is the current status of trial NCT03291743?
This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2017-02-10. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT03291743?
The interventions under investigation include: Capsule endoscopy (DEVICE).
Who is sponsoring clinical trial NCT03291743?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.